BenQ Medical Technology Corporation

TPEX:4116 Voorraadrapport

Marktkapitalisatie: NT$2.2b

BenQ Medical Technology Toekomstige groei

Future criteriumcontroles 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for BenQ Medical Technology.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Medical Equipment winstgroei23.0%
Inkomstengroein/a
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

None

Laatst bijgewerktn/a

Recente toekomstige groei-updates

Geen updates

Recent updates

There's Been No Shortage Of Growth Recently For BenQ Medical Technology's (GTSM:4116) Returns On Capital

Apr 07
There's Been No Shortage Of Growth Recently For BenQ Medical Technology's (GTSM:4116) Returns On Capital

Estimating The Fair Value Of BenQ Medical Technology Corporation (GTSM:4116)

Mar 23
Estimating The Fair Value Of BenQ Medical Technology Corporation (GTSM:4116)

BenQ Medical Technology's (GTSM:4116) Shareholders Are Down 49% On Their Shares

Mar 08
BenQ Medical Technology's (GTSM:4116) Shareholders Are Down 49% On Their Shares

Does BenQ Medical Technology Corporation (GTSM:4116) Have A Place In Your Dividend Stock Portfolio?

Feb 17
Does BenQ Medical Technology Corporation (GTSM:4116) Have A Place In Your Dividend Stock Portfolio?

BenQ Medical Technology (GTSM:4116) Seems To Use Debt Quite Sensibly

Jan 29
BenQ Medical Technology (GTSM:4116) Seems To Use Debt Quite Sensibly

BenQ Medical Technology Corporation's (GTSM:4116) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?

Jan 11
BenQ Medical Technology Corporation's (GTSM:4116) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?

The Returns At BenQ Medical Technology (GTSM:4116) Provide Us With Signs Of What's To Come

Dec 24
The Returns At BenQ Medical Technology (GTSM:4116) Provide Us With Signs Of What's To Come

BenQ Medical Technology's (GTSM:4116) Shareholders Are Down 72% On Their Shares

Dec 07
BenQ Medical Technology's (GTSM:4116) Shareholders Are Down 72% On Their Shares

Should You Buy BenQ Medical Technology Corporation (GTSM:4116) For Its 4.4% Dividend?

Nov 17
Should You Buy BenQ Medical Technology Corporation (GTSM:4116) For Its 4.4% Dividend?

In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat BenQ Medical Technology onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

TPEX:4116 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (TWD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
6/30/20244,597126264407N/A
3/31/20244,546115315422N/A
12/31/20234,543115303442N/A
9/30/20234,506101194353N/A
6/30/20234,46798300457N/A
3/31/20234,816115354493N/A
12/31/20224,377180403483N/A
9/30/20223,624169307372N/A
6/30/20222,885143186214N/A
3/31/20221,748112154178N/A
12/31/20211,4652988121N/A
9/30/20211,45548117164N/A
6/30/20211,44554142196N/A
3/31/20211,43259100155N/A
12/31/20201,40162109151N/A
9/30/20201,349543263N/A
6/30/20201,331595883N/A
3/31/20201,34863111131N/A
12/31/20191,38075148169N/A
9/30/20191,37080205238N/A
6/30/20191,33177158191N/A
3/31/20191,30782126159N/A
12/31/20181,2336788126N/A
9/30/20181,15455-128N/A
6/30/20181,14449-2446N/A
3/31/20181,08545N/A63N/A
12/31/20171,03747N/A73N/A
9/30/201798544N/A116N/A
6/30/201790142N/A99N/A
3/31/201787143N/A58N/A
12/31/201687646N/A71N/A
9/30/201692223N/A87N/A
6/30/201691322N/A63N/A
3/31/2016925115N/A59N/A
12/31/2015938118N/A86N/A
9/30/2015951149N/A50N/A
6/30/20151,022167N/A95N/A
3/31/20151,04682N/A126N/A
12/31/20141,01578N/A104N/A
9/30/201494569N/A131N/A
6/30/201486957N/A116N/A
3/31/201480643N/A115N/A
12/31/201380642N/A114N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Insufficient data to determine if 4116's forecast earnings growth is above the savings rate (1%).

Winst versus markt: Insufficient data to determine if 4116's earnings are forecast to grow faster than the TW market

Hoge groeiwinsten: Insufficient data to determine if 4116's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: Insufficient data to determine if 4116's revenue is forecast to grow faster than the TW market.

Hoge groei-inkomsten: Insufficient data to determine if 4116's revenue is forecast to grow faster than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Insufficient data to determine if 4116's Return on Equity is forecast to be high in 3 years time

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y